Yasemin Çakır Kıymaz | Biochemistry, Genetics and Molecular Biology | Academic Research Impact Award

Published on 03/01/202504/01/2025 by World Science Awards

Dr. Yasemin Çakır Kıymaz | Biochemistry, Genetics and Molecular Biology | Academic Research Impact Award

Sivas at Cumhuriyet University, Turkey

Dr. Yasemin Çakır Kıymaz is an accomplished Assistant Professor specializing in Infectious Diseases and Clinical Microbiology. She has dedicated her career to advancing medical research and education, with a particular focus on public health and infectious diseases. Her academic journey and professional expertise reflect a strong commitment to addressing critical healthcare challenges, including the prognosis of diseases such as Crimean-Congo Hemorrhagic Fever. Dr. Kıymaz has supervised impactful research projects and has served as a leader in infection control efforts. With memberships in numerous national and international professional organizations, she is recognized for her contributions to the scientific community. Her work bridges clinical practice and academic research, making her a valuable asset in medical science.

Profession Profile

Scopus Profile

Education

Dr. Kıymaz earned her bachelor’s degree in medicine in 2008, followed by a specialization in Infectious Diseases in 2016. Her academic achievements culminated in a thesis that explored factors affecting hospitalization durations of COVID-19 patients, reflecting her early contributions to emerging global health crises. She achieved her Assistant Professorship in 2021 and continues to build upon her expertise through academic and research endeavors. Her educational background underpins her robust understanding of infectious diseases and her commitment to improving patient care and health outcomes.

Professional Experience

Dr. Kıymaz has a comprehensive professional background, beginning as a Research Assistant at Düzce University in 2016, where she worked in the Department of Infectious Diseases and Clinical Microbiology. She later served as an Assistant Professor at Yozgat Bozok University from January to September 2023 before joining Sivas Cumhuriyet University in September 2023. Additionally, she chaired the Infection Control Committee at various institutions, leading efforts to implement effective infection prevention protocols. Her roles demonstrate a combination of academic leadership, research excellence, and practical contributions to healthcare.

Research Interests

Dr. Kıymaz’s research interests revolve around infectious diseases, with a focus on non-coding RNA and its role in the prognosis of diseases like Crimean-Congo Hemorrhagic Fever. Her work also extends to public health issues such as antimicrobial resistance, infection control, and vaccination strategies. Her dedication to exploring the molecular and clinical aspects of infectious diseases positions her as a significant contributor to advancing knowledge in her field.

Research Skills

Dr. Kıymaz possesses advanced research skills, including project management, clinical data analysis, and molecular biology techniques. She is adept at supervising theses and leading research projects, as evidenced by her work on the role of RNA in disease prognosis. Her expertise in infection control, epidemiology, and public health further underscores her technical and analytical abilities in addressing complex healthcare challenges.

Awards and Honors

Dr. Kıymaz has been recognized for her contributions to the medical field through memberships in esteemed organizations such as the European AIDS Clinical Society and the European Society of Clinical Microbiology and Infectious Diseases. These affiliations highlight her standing in the global research community. Her leadership in infection control committees and supervision of nationally funded research projects also reflects her recognition as a leader in her field.

Conclusion

Dr. Yasemin Çakır Kıymaz is a highly capable researcher and educator in the field of infectious diseases. Her academic achievements, professional experience, and dedication to impactful research make her a deserving candidate for prestigious awards. While her focus on public health and infection control is commendable, her potential for broader international recognition and interdisciplinary research marks her as a rising star in medical science.

Publication Top Notes

Title: Mortality rates and risk factors associated with mortality in patients with stenotrophomonas maltophilia primary Bacteraemia and Pneumonia
Authors: Hasbek, M., Aldemir, Ö., Çakır Kıymaz, Y., Yıldırım, D., Büyüktuna, S.A.
Year: 2025
Title: The great tularemia outbreak in Sivas: Evaluation of 205 cases
Authors: Çakır Kıymaz, Y., Bolat, S., Katırcı, B., Büyüktuna, S.A., Elaldi, N.
Year: 2025
Title: A rare case of necrotizing pneumonia due to brucellosis with blood and urine culture positivity
Authors: Çakır Kıymaz, Y., Yeşildağ, S., Hasbek, M., Büyüktuna, S.A., Elaldı, N.
Year: 2024
Title: Evaluation of Risk Factors Determining Focal Organ Involvement in Patients Diagnosed with Brucellosis | Bruselloz Tanılı Hastalarda Fokal Organ Tutulumunu Belirleyen Risk Faktörlerinin Değerlendirilmesi
Authors: Çakır-Kıymaz, Y., Sungur, M.A.
Year: 2024
Title: Exploring free amino acid profiles in Crimean-Congo hemorrhagic fever patients: Implications for disease progression
Authors: Büyüktuna, S.A., Yerlitaş, S.İ., Zararsız, G.E., Zararız, G., Doğan, H.O.
Year: 2024
Title: Exploring free amino acid profiles in CCHF patients: Implications for disease progression
Authors: Büyüktuna, S.A., Yerlitaş, S.İ., Zararsız, G.E., Zararız, G., Doğan, H.O.
Year: 2024
Title: A Case of Hantavirus Renal Syndrome Detected in the COVID-19 Pandemic | COVID-19 Pandemisinde Saptanan Hantavirüs Renal Sendrom Olgusu
Authors: Çakir, Y., İnce, N.
Year: 2024
Title: Frequency of Hepatosteatosis and Relationship Between Laboratory Parameters and Hepatosteatosis in Chronic Hepatitis B Patients | Kronik Hepatit B Hastalarında Hepatosteatoz Sıklığı ve Laboratuvar Parametrelerin Hepatosteatoz ile İlişkisinin Değerlendirilmesi
Authors: Çakır, Y., Sungur, M.A., Öz, M., Büyüktuna, S.A.
Year: 2024
Title: Surgical Antimicrobial Prophylaxis Compliance in Turkey: Data from the Prospective, Observational, Multicenter Survey Including 7,978 Surgical Patients
Authors: Çelik Ekinci, S., Yenilmez, E., Akengin Öcal, G., Raşa, H.K., Köse, Ş.
Year: 2024
Title: Multiple Cerebral Hydatic Cyst Developed After Operation of Cardiac Hydatic Cyst: A Case Report | Kardiyak Hidatik Kist Operasyonu Sonrası Gelişen Multiple Serebral Kist Hidatik: Olgu Sunumu
Authors: Mutlu, İ., Koyuncu, Ö.R., Çakır, Y.
Year: 2024

Wenguang Yin | Molecular Biology | Best Researcher Award

Published on 26/12/202426/12/2024 by World Science Awards

Prof. Dr. Wenguang Yin | Molecular Biology | Best Researcher Award

Group leader at Guangzhou Medical University, China

Wenguang Yin is a distinguished researcher in the field of regenerative biology, with a focus on respiratory diseases, stem cell biology, and cellular signaling. Currently serving as a group leader at the State Key Laboratory of Respiratory Disease at Guangzhou Medical University, Yin has made significant contributions to understanding the molecular mechanisms underlying lung development, smooth muscle biology, and airway diseases. His work is particularly impactful in the context of respiratory health and regenerative medicine. With a strong academic background and postdoctoral training under leading experts, Yin has published extensively in high-impact journals, contributing to advancements in translational medicine. His leadership in guiding a research team and his role as a corresponding author in numerous studies further demonstrate his commitment to advancing scientific knowledge. Yin’s dedication to exploring the genetic and cellular foundations of lung diseases positions him as a trailblazer in the field.

Professional Profile

Scopus Profile

Education:

Wenguang Yin’s academic journey began with a B.S. degree in Biological Engineering from Dalian University of Technology, followed by a second B.S. degree in English, reflecting his interdisciplinary approach. He then pursued a Ph.D. in Regenerative Biology at the South China Institute for Stem Cell Biology and Regenerative Medicine. His doctoral research, conducted in the lab of Prof. Duanqing Pei, provided a solid foundation in stem cell biology and regenerative medicine. This was followed by postdoctoral fellowships at top international institutes, including the Max Planck Institute for Heart and Lung Research and Justus Liebig University Giessen, where Yin expanded his expertise in developmental genetics and lung biology. His educational background reflects a unique blend of scientific rigor and global exposure, equipping him to lead high-impact research on lung disease and cellular regeneration.

Professional Experience:

Wenguang Yin’s professional trajectory reflects a blend of expertise in developmental genetics, regenerative biology, and respiratory health. Starting as a Ph.D. fellow at the South China Institute for Stem Cell Biology and Regenerative Medicine, Yin laid the groundwork for his research in cellular signaling pathways and stem cell mechanisms. His postdoctoral fellowships at the prestigious Max Planck Institute and Justus Liebig University Giessen provided Yin with valuable international experience, working with leading scientists in developmental genetics and lung research. Yin’s current role as a group leader at the State Key Laboratory of Respiratory Disease at Guangzhou Medical University allows him to apply his diverse experience in leading cutting-edge research on airway diseases and lung regeneration. His leadership in the lab and his role in several high-impact projects solidify his position as a key contributor to the global scientific community in the areas of respiratory medicine and regenerative biology.

Research Interests:

Wenguang Yin’s research interests are centered on understanding the molecular and cellular mechanisms that govern lung development, respiratory diseases, and tissue regeneration. His work specifically focuses on how cellular signaling pathways influence smooth muscle cytoskeletal organization, airway epithelial remodeling, and tissue repair. Yin is also keenly interested in studying the impact of external factors, such as e-cigarette vapor, on lung health. His research integrates cutting-edge techniques in single-cell transcriptomics, gene editing, and molecular biology to uncover the genetic and biochemical networks involved in lung function and regeneration. A significant aspect of his research is exploring the role of key cellular proteins, ion channels, and extracellular matrix components in lung disease. By addressing these fundamental questions, Yin aims to contribute to the development of novel therapeutic strategies for respiratory disorders, including asthma, chronic obstructive pulmonary disease (COPD), and lung fibrosis.

Research Skills:

Wenguang Yin possesses a robust skill set in molecular biology, cellular biology, and developmental genetics, making him an expert in conducting high-level research on lung development and regenerative medicine. His technical proficiency includes single-cell transcriptomics, advanced gene editing techniques like CRISPR-Cas9, and immunohistochemistry. Yin is adept at utilizing model organisms, including mice and zebrafish, to study the cellular and molecular underpinnings of lung diseases and regeneration. Additionally, his experience in analyzing complex data sets through bioinformatics tools allows him to integrate large-scale genetic and transcriptomic data for more comprehensive insights into lung biology. Yin’s interdisciplinary background also allows him to approach research from a unique perspective, incorporating both biomedical engineering and molecular genetics to investigate the role of cellular structures in disease progression and tissue repair. His ability to design and implement innovative research methodologies has been a cornerstone of his scientific success.

Awards and Honors:

Wenguang Yin has earned recognition for his contributions to the field of regenerative biology and respiratory research through multiple prestigious awards and honors. His work, published in high-impact journals, has been instrumental in advancing our understanding of lung diseases and cellular regeneration. As a corresponding author in numerous influential studies, Yin’s leadership in research has been acknowledged in the scientific community. While specific awards and honors are not listed in detail, his consistent recognition through impactful publications, his leadership role in major research projects, and his position as a group leader at a renowned institute reflect the high regard in which he is held within the research community. His expertise, innovative contributions, and international collaborations are key factors in his growing reputation as a leading researcher in respiratory medicine and regenerative biology.

Conclusion:

Wenguang Yin is a highly accomplished researcher whose work is shaping the future of respiratory medicine and regenerative biology. With a solid educational foundation, extensive international research experience, and a commitment to understanding the molecular mechanisms behind lung development and disease, Yin has become a leader in his field. His groundbreaking research, including high-impact publications in top journals, demonstrates his ability to address critical questions in lung health and regeneration. Although further interdisciplinary collaboration and broader dissemination of his work could enhance its clinical impact, Yin’s expertise and leadership make him a deserving candidate for continued recognition and accolades in the scientific community. His research holds immense potential for advancing therapies for respiratory diseases and improving patient outcomes in the future.

Publication Top Notes

Tropism of adeno-associated virus serotypes in mouse lungs via intratracheal instillation
- Authors: Wu, H., Zhao, A., Bu, Y., Li, H., Yin, W.
- Year: 2024
Single-cell transcriptomics reveals e-cigarette vapor-induced airway epithelial remodeling and injury
- Authors: Cao, W., Li, J., Che, L., Yin, W., Ran, P.
- Year: 2024
The T-Type Calcium Channel CACNA1H is Required for Smooth Muscle Cytoskeletal Organization During Tracheal Tubulogenesis
- Authors: Liu, Z., Lu, C., Ma, L., Stainier, D.Y.R., Yin, W.
- Year: 2024
- Citations: 1
Epigenetic regulation of macrophage activation in chronic obstructive pulmonary disease
- Authors: Zhang, F., Cui, Y., Zhang, T., Yin, W.
- Year: 2024
SARS-CoV-2 spike protein induces IL-18-mediated cardiopulmonary inflammation via reduced mitophagy
- Authors: Liang, S., Bao, C., Yang, Z., Desai, A.A., Tang, H.
- Year: 2023
- Citations: 28
The Mechanisms of Resistin-Like Molecule-βMediated Airway Inflammation in Chronic Obstructive Pulmonary Disease via Autophagy
- Authors: Che, L., Xie, Z., Chen, G., Cai, X., Liu, S.
- Year: 2023
Systematic Analysis of Smooth Muscle and Cartilage Ring Formation during Mouse Tracheal Tubulogenesis
- Authors: Wu, H., Wang, P., Liu, Z., Lu, C., Yin, W.
- Year: 2023
Deleterious synonymous mutation identification based on selective ensemble strategy
- Authors: Wang, L., Zhang, T., Yu, L., Xia, J., Zhang, T.
- Year: 2023
An essential function for autocrine hedgehog signaling in epithelial proliferation and differentiation in the trachea
- Authors: Yin, W., Liontos, A., Koepke, J., Stainier, D.Y.R., Samakovlis, C.
- Year: 2022
- Citations: 10
Potent prophylactic and therapeutic efficacy of recombinant human ACE2-Fc against SARS-CoV-2 infection in vivo
- Authors: Zhang, Z., Zeng, E., Zhang, L., Shao, W., Zhao, J.
- Year: 2021
- Citations: 50

Pi-Wan Cheng | Molecular Biology | Best Researcher Award

Published on 04/12/202404/12/2024 by World Science Awards

Prof. Dr. Pi-Wan Cheng | Molecular Biology | Best Researcher Award

Professor at University of Nebraska Medical Center, United States

Dr. Pi Wan Cheng is a distinguished biochemist and molecular biologist with over four decades of experience in research and academia. He currently holds a professorship at the University of Nebraska Medical Center (UNMC) and has contributed significantly to the field of glycobiology. Dr. Cheng has made pivotal advancements in understanding glycan biosynthesis and its role in health, diseases, and cancer. His work, which bridges basic and translational research, is supported by multiple research grants and patents. He has also been an active member of several professional organizations, underscoring his influence in the scientific community. Dr. Cheng’s research focuses on how glycosylation affects immune responses and cancer progression, with a special emphasis on the development of Siglec-7-based therapies for pancreatic cancer.

Professional Profile

Scopus Profile

Education:

Dr. Pi Wan Cheng obtained his Ph.D. in Biochemistry from Case Western Reserve University, Cleveland, Ohio, in 1975. Prior to that, he earned his M.S. in Biochemistry from National Taiwan University in 1968, following his B.S. in Agricultural Chemistry from the same institution in 1965. Throughout his educational journey, Dr. Cheng worked under the mentorship of prominent scientists such as Dr. Don M. Carlson and Dr. Kuo Huang Ling, which shaped his academic and professional growth in biochemistry and molecular biology.

Professional Experience:

Dr. Cheng’s career spans numerous prestigious academic institutions. He has held faculty positions at Case Western Reserve University, the University of North Carolina, and UNMC. At UNMC, he has been a professor in the Department of Biochemistry and Molecular Biology since 1995, where he was granted tenure in 1997. He also served as a research chemist at the Veterans Affairs Nebraska Western Iowa Health Care System from 2011 to 2017. His role at UNMC also includes courtesy appointments in the College of Pharmacy and the Eppley Institute for Cancer Research, where he has fostered collaborations and contributed to the institution’s research landscape.

Research Interest:

Dr. Cheng’s primary research interest lies in glycobiology, specifically the mechanisms of glycan biosynthesis and its impact on health and disease. His work focuses on understanding how glycans, particularly sialylated O-glycans, influence immune responses and contribute to the progression of diseases such as cancer. He investigates how specific glycans, induced by factors like interleukin-6 and alcohol, can protect cancer cells from immune surveillance and promote tumor growth. His innovative research is also exploring therapies targeting Siglec-7 for pancreatic cancer treatment, with potential applications in immunotherapy and cancer prevention.

Research Skills:

Dr. Cheng possesses a comprehensive skill set in biochemistry, molecular biology, and glycobiology. He is skilled in techniques related to protein biochemistry, glycan analysis, immunology, and cancer research. His expertise includes the development of molecular models to understand glycan interactions with immune cells, as well as employing various biochemical assays to assess glycan expression in disease states. Dr. Cheng’s proficiency extends to experimental design, grant writing, and leading interdisciplinary research teams. He has also contributed to the field through patents, underscoring his ability to translate fundamental discoveries into real-world applications.

Awards and Honors:

Throughout his career, Dr. Cheng has received numerous accolades for his groundbreaking research in glycobiology. His work has been supported by prestigious grants, including those from the Nebraska Department of Health and Human Services, where he has led multiple research projects related to cancer and immune function. He holds patents in biologically active molecule delivery, reflecting his innovative contributions to science. Dr. Cheng is a lifetime member of the Society for Glycobiology and the Society of Chinese Bioscientists in America, and he has been recognized for his service to the scientific community through various professional society memberships and community volunteer work.

Conclusion:

Dr. Pi Wan Cheng is a highly qualified candidate for the Best Researcher Award, with a distinguished career marked by significant research contributions in glycobiology, a track record of continuous funding, and active involvement in the scientific community. His innovative research, particularly in cancer immunology and glycosylation, holds great promise for medical advancements. While there is room for further interdisciplinary collaboration and publication visibility, his foundational work in glycobiology makes him a deserving nominee for this prestigious award.

Publication Top Notes

Markers of malignant prostate cancer cells: Golgi localization of α-mannosidase 1A at GM130-GRASP65 site and appearance of high mannose N-glycans on cell surface
- Authors: Cheng, P.-W., Davidson, S., Bhat, G.
- Year: 2020
- Citations: 12
Inhibitory activity of salivary glycoproteins on phytohemagglutins (PHA): Possible molecules to enhance nutritional quality of red kidney beans
- Authors: Chachadi, V.B., Nayanegali, T.R., Pujari, B.G., Inamdar, S.R., Cheng, P.-W.
- Year: 2020
- Citations: 3
p66Shc protein through a redox mechanism enhances the progression of prostate cancer cells towards castration-resistance
- Authors: Miller, D.R., Ingersoll, M.A., Chatterjee, A., Oberley-Deegan, R.E., Lin, M.-F.
- Year: 2019
- Citations: 18
Shifted Golgi targeting of glycosyltransferases and α-mannosidase IA from giantin to GM130-GRASP65 results in formation of high mannose N-glycans in aggressive prostate cancer cells
- Authors: Bhat, G., Hothpet, V.-R., Lin, M.-F., Cheng, P.-W.
- Year: 2017
- Citations: 18
The role of Rab6a and phosphorylation of non-muscle myosin IIA tailpiece in alcohol-induced Golgi disorganization
- Authors: Petrosyan, A., Casey, C.A., Cheng, P.-W.
- Year: 2016
- Citations: 22
Downregulation of the small GTPase SAR1A: A key event underlying alcohol-induced Golgi fragmentation in hepatocytes
- Authors: Petrosyan, A., Cheng, P.-W., Clemens, D.L., Casey, C.A.
- Year: 2015
- Citations: 20
Glycosyltransferases involved in the synthesis of MUC-associated metastasis-promoting selectin ligands
- Authors: Chachadi, V.B., Bhat, G., Cheng, P.-W.
- Year: 2015
- Citations: 15
Keratin 1 plays a critical role in Golgi localization of core 2 N-acetylglucosaminyltransferase M via interaction with its cytoplasmic tail
- Authors: Petrosyan, A., Ali, M.F., Cheng, P.-W.
- Year: 2015
- Citations: 20
Restoration of compact Golgi morphology in advanced prostate cancer enhances susceptibility to galectin-1-induced apoptosis by modifying mucin O-glycan synthesis
- Authors: Petrosyan, A., Holzapfel, M.S., Muirhead, D.E., Cheng, P.-W.
- Year: 2014
- Citations: 64
Golgi fragmentation induced by heat shock or inhibition of heat shock proteins is mediated by non-muscle myosin IIA via its interaction with glycosyltransferases
- Authors: Petrosyan, A., Cheng, P.-W.
- Year: 2014
- Citations: 24

Lan Hong | Biochemistry | Best Researcher Award

Published on 15/11/202415/11/2024 by World Science Awards

Prof. Lan Hong | Biochemistry | Best Researcher Award

Professor at Yanbian University, China

Dr. Lan Hong, a Professor in the Department of Physiology and Pathophysiology at Yanbian University’s College of Medicine, has dedicated her career to advancing knowledge in cardiovascular physiology, with a specialized focus on cardiac protection mechanisms and stem cell therapy. With over 18 years of experience, Dr. Hong’s research addresses critical challenges in cardiovascular health, particularly in understanding and treating ischemia-reperfusion injuries and myocardial infarction. She has made substantial contributions to the field through high-impact publications, collaborative research initiatives, and conference presentations. As a recognized figure in her field, she has also served as a visiting scholar at Texas A&M University-Commerce, where she expanded her work on regenerative medicine, specifically focusing on cardiac-induced RNA and pluripotent stem cells. Dr. Hong’s research is well-cited, with an H-index of 10 and a citation count of over 300, reflecting her influence in cardiac physiology research. Her extensive involvement in academic conferences, journal reviews, and mentoring has bolstered her reputation as a leader in cardiovascular research. She is also recognized through multiple awards and invitations to present her research, which underscores her commitment to advancing the understanding and treatment of cardiovascular diseases.

Professional Profile

Google Scholar Profile

Education

Dr. Lan Hong’s educational journey is anchored in her commitment to understanding the intricacies of cardiovascular physiology. She earned her PhD in Physiology from Yanbian University in 2012, where she also completed her MSc in the same field in 2009. Prior to her postgraduate studies, she graduated with a degree in Clinical Medicine from Yanbian University in 2006, which laid the foundation for her subsequent research in cardiac health. Her academic path reflects a deep specialization in cardiac physiology, particularly in exploring protective mechanisms for the heart and developing innovative treatments for cardiovascular diseases. Throughout her education, Dr. Hong cultivated a robust theoretical and practical understanding of physiology, providing a strong foundation for her later research on myocardial infarction and stem cell therapy. Her scholarly background, coupled with hands-on experience in clinical medicine, has greatly enriched her approach to research, enabling her to bridge the gap between theoretical knowledge and clinical application in her ongoing studies.

Professional Experience

Dr. Lan Hong has built a distinguished career as a cardiovascular researcher, currently serving as a Professor at the College of Medicine at Yanbian University, where she has worked since 2013. She initially joined the university’s Department of Physiology and Pathophysiology as an Assistant Professor, where her research began to focus on ischemia-reperfusion injury and cardiac fibrosis mechanisms. Her career includes international experience as a visiting scholar and postdoctoral researcher at Texas A&M University-Commerce from 2017 to 2018. During her tenure there, she collaborated on groundbreaking work using cardiac-inducing RNA and stem cell technology for post-infarction heart repair. Dr. Hong’s role as an educator and mentor is integral to her professional experience, as she has supervised graduate students, organized research conferences, and contributed as a reviewer for respected journals. Her professional trajectory reflects a consistent dedication to advancing cardiovascular health and supporting academic development in her field, cementing her reputation as a respected academic and researcher in cardiovascular physiology.

Research Interests

Dr. Lan Hong’s research interests center on cardiovascular physiology, with a particular emphasis on mechanisms of cardiac protection and regeneration. Her work seeks to address key challenges in treating myocardial infarction and mitigating ischemia-reperfusion injury. One of her primary research interests is exploring molecular pathways such as the Sirt1/Nrf2/ATF3/4 axis and the role of ferroptosis in cardiac injury. Additionally, Dr. Hong is committed to advancing stem cell therapy, specifically investigating the regenerative potential of induced pluripotent stem cells in cardiac repair. Her studies also delve into the role of long non-coding RNAs (lncRNAs) in modulating cellular responses to injury and in promoting cardiomyocyte regeneration. By targeting these cellular pathways, Dr. Hong aims to develop novel therapeutic approaches that offer improved outcomes for patients with cardiovascular conditions. Her research interests reflect a balanced approach that combines molecular biology, regenerative medicine, and clinical application, making significant strides in cardiovascular health advancements.

Research Skills

Dr. Lan Hong’s research skills are rooted in a robust knowledge of cardiovascular physiology, paired with technical expertise in cellular and molecular biology techniques. She is proficient in various lab methodologies essential to cardiac physiology research, including in vitro and in vivo models for studying ischemia-reperfusion injury and myocardial infarction. Dr. Hong’s work with stem cells, particularly induced pluripotent stem cells, requires advanced skills in cellular reprogramming and RNA-mediated gene expression techniques. Her proficiency extends to molecular techniques such as Western blotting, immunohistochemistry, and real-time PCR, which she utilizes to investigate gene expression patterns and protein signaling in cardiac tissues. Her ability to perform complex experimental procedures, analyze data critically, and interpret results within the context of cardiovascular health has made her research impactful and well-regarded. Dr. Hong’s research skills are complemented by her collaborative approach, which has facilitated cross-disciplinary studies and allowed her to mentor students effectively, contributing to the next generation of cardiovascular researchers.

Awards and Honors

Throughout her career, Dr. Lan Hong has received recognition for her contributions to cardiovascular research. Her work has earned her multiple awards, reflecting her expertise and influence in cardiac physiology. She has been invited to present her findings at national and international conferences, showcasing her research on ischemia-reperfusion injury and stem cell therapy. Her role as an invited speaker demonstrates the high regard in which her peers hold her work and highlights her contributions to advancing cardiovascular health. Additionally, Dr. Hong’s editorial and peer-review roles for respected journals underscore her commitment to maintaining rigorous standards in scientific research and her influence in the academic community. Her research achievements, high-impact publications, and the positive impact of her mentorship have solidified her standing as a leader in cardiovascular physiology. Her recognition through these awards and honors underscores her dedication to her field and highlights her impact on the scientific understanding of cardiac health and disease.

Conclusion

Lan Hong’s extensive research and contributions in cardiovascular physiology, along with her impactful publications, make her a strong candidate for the Best Researcher Award. Her international experience, academic achievements, and innovative work in cardiac protection mechanisms are commendable. Addressing minor gaps in industry collaboration and expanding her professional presence may further strengthen her profile for future recognitions. Overall, her dedication to advancing cardiovascular health and her achievements make her highly deserving of the award.

Publications Top Notes

Synthesis and antibacterial evaluation of rhodanine-based 5-aryloxy pyrazoles against selected methicillin-resistant and quinolone-resistant Staphylococcus aureus (MRSA and QRSA)”
Authors: MX Song, CJ Zheng, XQ Deng, LP Sun, Y Wu, L Hong, YJ Li, Y Liu, …
Journal: European Journal of Medicinal Chemistry, 60, 376-385
Year: 2013
Citations: 57
“MAPK and PI3K pathways regulate hypoxia-induced atrial natriuretic peptide secretion by controlling HIF-1 alpha expression in beating rabbit atria”
Authors: Q Zhang, B Cui, H Li, P Li, L Hong, L Liu, D Ding, X Cui
Journal: Biochemical and Biophysical Research Communications, 438 (3), 507-512
Year: 2013
Citations: 38
“Atrial natriuretic peptide prevents the mitochondrial permeability transition pore opening by inactivating glycogen synthase kinase 3β via PKG and PI3K in cardiac H9c2 cells”
Authors: L Hong, J Xi, Y Zhang, W Tian, J Xu, X Cui, Z Xu
Journal: European Journal of Pharmacology, 695 (1-3), 13-19
Year: 2012
Citations: 37
“Synthesis and biological evaluation of 5-aryloxypyrazole derivatives bearing a rhodanine-3-aromatic acid as potential antimicrobial agents”
Authors: CJ Zheng, MX Song, LP Sun, Y Wu, L Hong, HR Piao
Journal: Bioorganic & Medicinal Chemistry Letters, 22 (23), 7024-7028
Year: 2012
Citations: 35
“Synthesis and positive inotropic activity of N-(4, 5-dihydro-[1, 2, 4] triazolo [4, 3-a] quinolin-7-yl)-2-(piperazin-1-yl) acetamide derivatives”
Authors: CB Zhang, X Cui, L Hong, ZS Quan, HR Piao
Journal: Bioorganic & Medicinal Chemistry Letters, 18 (16), 4606-4609
Year: 2008
Citations: 26
“Adenosine A2 receptor activation ameliorates mitochondrial oxidative stress upon reperfusion through the posttranslational modification of NDUFV2 subunit of complex I in the heart”
Authors: J Xu, X Bian, Y Liu, L Hong, T Teng, Y Sun, Z Xu
Journal: Free Radical Biology and Medicine, 106, 208-218
Year: 2017
Citations: 22
“Ethanol attenuates sensory stimulus-evoked responses in cerebellar granule cells via activation of GABAA receptors in vivo in mice”
Authors: G Wu, H Liu, J Jin, L Hong, Y Lan, CP Chu, DL Qiu
Journal: Neuroscience Letters, 561, 107-111
Year: 2014
Citations: 19
“Ouabain stimulates atrial natriuretic peptide secretion via the endothelin-1/ETB receptor-mediated pathway in beating rabbit atria”
Authors: L Liu, L Hong, L Yu, H Li, D Ding, S Jin, X Cui
Journal: Life Sciences, 90 (19-20), 793-798
Year: 2012
Citations: 16
“Cathepsins in the extracellular space: Focusing on non-lysosomal proteolytic functions with clinical implications”
Authors: H Wang, A Inoue, Y Lei, H Wu, L Hong, XW Cheng
Journal: Cellular Signalling, 103, 110531
Year: 2023
Citations: 13

Ameni Hadj Mohamed | Glycopeptides | Best Researcher Award

Published on 11/11/202413/11/2024 by World Science Awards

Ameni Hadj Mohamed | Glycopeptides | Best Researcher Award

Post-doctoral researcher at Université Paris-Saclay and École Polytechnique, France.

Ameni Hadj Mohamed is an accomplished researcher in organic and medicinal chemistry, specializing in organic synthesis, organometallic catalysis, and carbohydrate chemistry. She holds a PhD from Sorbonne University and currently works as a postdoctoral researcher at Université Paris-Saclay and École Polytechnique, France. Her research focuses on developing new compounds with potential applications in treating infectious diseases and cancer.

Professional Profile

Education

Ameni completed her PhD in Organic Chemistry at Sorbonne University in 2020, focusing on heterocyclic molecules for antibacterial and anticancer activities. She earned her Master’s degree in Synthesis and Reactivity in Organic Chemistry from Monastir University, Tunisia, where she graduated as valedictorian in 2017.

Professional Experience

Ameni has worked as a postdoctoral researcher at prominent institutions such as Université Paris-Saclay and Ecole Polytechnique. Her research has focused on Pd-catalyzed organic reactions, glycopeptides, and the development of compounds for treating respiratory infections and neurodegenerative diseases.

Research Interests

Her research interests include organic synthesis, organometallic catalysis, carbohydrate chemistry, and the development of novel therapeutic agents targeting cancer, infections, and neurodegenerative diseases.

Research Skills

Ameni possesses expertise in multiparametric optimization, the synthesis of small organic molecules, biological evaluation, and scaling-up chemical reactions. She also specializes in deep chemical and photophysical characterization of fluorescent compounds and drug development.

Awards and Honors

Ameni has received several prestigious awards, including the Eiffel Excellence Program funding (2019), Best Oral Communication Award at the SCF Congress (2018), and a Poster Award at the French-American Chemical Symposium (2024). She has also received grants for international conferences from the Agence Universitaire de Francophonie.

Conclusion

Ameni Hadj Mohamed demonstrates exceptional expertise, a track record of high-quality research, and recognition within her field. Her innovative contributions in organic chemistry, particularly in medicinal chemistry, show promise in making meaningful impacts on global health challenges, including cancer and infectious diseases. She has an outstanding academic record and continues to grow as both a researcher and educator.

Publication Top Notes

Recent advances in aza Friedel–Crafts reaction: strategies for achiral and stereoselective synthesis
Authors: AH Mohamed, N Masurier
Year: 2023
Citation count: 19
Journal: Organic Chemistry Frontiers, 10(7), 1847-1866
Novel Set of Diarylmethanes to Target Colorectal Cancer: Synthesis, In Vitro and In Silico Studies
Authors: A Hadj Mohamed, A Pinon, N Lagarde, E Goya Jorge, H Mouhsine, et al.
Year: 2022
Citation count: 3
Journal: Biomolecules, 13(1), 54
Synthesis of some new diarylmethanes by McMurry coupling reaction: Characterization and antibacterial activity
Authors: AH Mohamed, M Görmen, M El Arbi, M Msaddek, MSI Veitia
Year: 2019
Citation count: 1
Journal: MDPI AG
Front Cover: A Promising Approach to Target Colorectal Cancer Using Hybrid Triarylmethanes
Authors: A Hadj Mohamed, C Ricco, A Pinon, N Lagarde, E Goya‐Jorge, et al.
Year: 2024
Citation count: N/A (future publication)
Journal: ChemMedChem, 19(21), e202482101
A Promising Approach to Target Colorectal Cancer Using Hybrid Triarylmethanes
Authors: A Hadj Mohamed, C Ricco, A Pinon, N Lagarde, E Goya‐Jorge, et al.
Year: 2024
Citation count: N/A (future publication)
Journal: ChemMedChem, 19(21), e202400151
Diastereoselective Anomeric C (sp3)-H Cyclization Towards the Design of New Generations of Cyclophane-Braced Glycopeptides
Authors: S Bazzi, AH Mohamed, D Ryzhakov, J Ghouilem, MA Beniddir, V Gandon, et al.
Year: 2024
Citation count: N/A (future publication)
Journal: N/A
Novel Pyridyl Macrocyclic Triarylmethanes: Synthesis by Ring-Closing Metathesis and Chemical Analysis
Authors: MMMSIV Ameni Hadj Mohamed, Corinne Coutant
Year: 2024
Citation count: N/A (future publication)
Journal: Current Organic Synthesis, 21, 1-10
Colorectal anticancer activity of a novel class of triazolic triarylmethane derivatives
Authors: AH Mohamed, A Pinon, N Lagarde, C Ricco, E Goya-Jorge, H Mouhsine, et al.
Year: 2024
Citation count: N/A (future publication)
Journal: RSC Medicinal Chemistry, 15(2), 660-676
Diarylmethanes as potential anti colorectal cancer agents: Synthesis, In vitro and in silico studies
Authors: M Sylla-Iyarreta, AH Mohamed, A Pinon, N Lagarde, B Liagre
Year: 2023
Citation count: N/A
Conference: 30ème Young Research Fellows Meeting
Development of new molecules of the di and triarylmethane type for antibacterial and anticancer purposes: synthesis, characterization and biological studies
Author: AH Mohamed
Year: 2020
Citation count: N/A
Institution: Sorbonne Université; Université de Monastir (Tunisie)

Dr. Florence Back | Biochemistry | Best Researcher Award

Published on 30/10/202430/10/2024 by World Science Awards

Dr. Florence Back | Biochemistry | Best Researcher Award

Doctorate at University of Lille, France

Florence Back is a distinguished biomaterials scientist and researcher specializing in bioadhesive and smart wound-healing technologies. Based in Strasbourg, France, she has made significant strides in developing innovative materials for medical applications, including hydrogels and electronic patches for therapeutic uses. Florence’s work is underpinned by advanced training in in vivo procedures and applied chemistry, making her well-versed in both the laboratory synthesis of biomaterials and preclinical surgical applications. Her research has been published in reputable journals, highlighting her commitment to advancing the fields of bioengineering and regenerative medicine. Florence’s research integrates expertise across biology, chemistry, and physics, emphasizing both material functionality and patient-centered applications. She has been involved in collaborative research at prestigious institutions, including CNRS Lille and UC Louvain, and is actively expanding her interdisciplinary contributions to wound care, tissue repair, and bioengineering.

Professional Profile

Education

Florence holds a Ph.D. in Biomaterials from UNISTRA Strasbourg, completed in 2022, where she focused on the synthesis and development of bioadhesives based on gelatin and catechol. This work involved extensive research into the formulation, spectroscopic characterization, and rheological analysis of these bioadhesives. Her doctoral studies were preceded by two specialized master’s degrees, both from UNISTRA Strasbourg, in supramolecular and macromolecular chemistry, completed in 2020 and 2019, respectively. Florence’s master’s education covered advanced techniques in organic and polymer synthesis, including the creation of fluorescent molecules and polymers with unique biochemical properties. Her academic journey includes a series of certifications in in vivo procedures from CNRS Lille, where she developed critical surgical skills required for research involving animal models. Florence’s education has been integral in building her comprehensive understanding of biomaterials and in vivo applications, positioning her as a skilled researcher in medical and chemical sciences.

Professional Experience

Florence’s professional experience includes postdoctoral research and engineering roles focused on advancing biomaterial applications in medicine. Currently, she is a postdoctoral researcher at UC Louvain in Belgium, working on the AI-SWEEP-2 project, which involves the synthesis of electronic patches for smart bandages intended for human use. Prior to this, she served as a biomaterials engineer at CNRS Lille, where she contributed to the ANR Gskin project, focusing on synthesizing and characterizing hydrogels doped with extracellular vesicles for diabetic wound healing. From 2020 to 2022, during her Ph.D. at the Dental Faculty of Strasbourg, Florence specialized in the synthesis of bioadhesives based on gelatin and catechol, marking the beginning of her notable contributions to biomaterials science. These roles have allowed her to develop an integrated approach to material synthesis, characterization, and biological application, emphasizing her commitment to innovation in therapeutic and regenerative materials.

Research Interests

Florence’s research interests center on biomaterials, bioadhesives, and smart wound-healing technologies. Her primary focus is the development and synthesis of bioadhesive hydrogels, which hold promise in tissue repair and regenerative medicine. Additionally, her work extends to smart bandages, integrating electronic patches for wound monitoring and therapeutic delivery, aimed at improving patient outcomes in wound care. She is also interested in the extraction and application of extracellular vesicles in biomaterials, with specific attention to their role in promoting cellular viability and tissue regeneration. Florence’s research leverages a multidisciplinary approach, combining chemistry, biology, and materials science to create innovative solutions that bridge the gap between synthetic materials and biological functions. Her commitment to research that addresses clinical challenges underscores her dedication to advancing biomaterials for direct medical applications.

Research Skills

Florence’s research skills encompass a wide range of laboratory and analytical techniques, particularly in chemistry, biology, and materials science. She is proficient in organic and polymer synthesis, including gel formulation and the development of bioadhesive materials from gelatin, chitosan, and silk hydrogels. Her technical skills include chromatography, spectroscopy (NMR, IR, UV-Vis), and nanoparticle tracking analysis, which she applies in the characterization of synthesized materials. Florence is also skilled in in vivo procedures, certified for surgeries and techniques on various animal models, such as vascular catheterization, cerebral ischemia, and renal grafting. Additionally, her experience extends to cell culture, viability testing, and supervising research protocols. Florence’s ability to conduct comprehensive material characterization combined with her surgical training in vivo highlights her versatility and readiness to bridge laboratory research with applied medical sciences.

Awards and Honors

Florence has achieved various recognitions that reflect her dedication to research excellence in biomaterials. Her doctoral research at UNISTRA Strasbourg earned her acclaim for creating bioadhesive formulations with potential applications in tissue engineering and wound care. Her work has been published in notable journals, including Frontiers in Materials and Gels, indicating her research’s value to the academic and clinical communities. Florence’s role in collaborative projects, such as the ANR Gskin and AI-SWEEP-2, highlights her contributions to interdisciplinary research initiatives aimed at developing innovative therapeutic technologies. Additionally, her certifications in in vivo procedures from CNRS Lille are a testament to her commitment to ethical and skillful research practices. Florence’s career trajectory, marked by research achievements and collaborative contributions, positions her as a promising candidate for awards in scientific innovation and applied biomaterials.

Conclusion

Florence Back demonstrates strong candidacy for a “Best Researcher Award” due to her advanced technical skills in biomaterials, substantial in vivo training, and impactful research in bioadhesives and smart bandage technologies. By addressing minor language skills and pursuing independent research initiatives, she could amplify her contributions and influence in the field.

Publication Top Notes

Optimization of the Elasticity and Adhesion of Catechol- or Dopamine-Loaded Gelatin Gels under Oxidative Conditions
- Authors: F. Back, E. Mathieu, C. Betscha, Y. Arntz, V. Ball
- Journal: Gels
- Year: 2022
- Volume & Issue: 8(4), Article 210
- Citations: 7
- Open Access: Yes
Influence of the NaIO₄ Concentration on the Gelation and the Adhesive Strength of Pyrocatechol/Pyrogallol Containing Gelatin Hydrogels
- Authors: F. Back, V. Ball, Y. Arntz
- Journal: Frontiers in Materials
- Year: 2021
- Volume & Article: 8, Article 671451
- Citations: 4
- Open Access: Yes

Mohammad Sadegh Hashemzadeh | Biochemistry |Best Researcher Award

Published on 02/09/202402/09/2024 by World Science Awards

Assist Prof Dr. Mohammad Sadegh Hashemzadeh | Biochemistry |Best Researcher Award

Assist. Professor at Nanobiotechnology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran

Dr. Mohammad Sadegh Hashemzadeh is an accomplished Assistant Professor at Baqiyatallah University of Medical Sciences, specializing in Medical and Nano Biotechnology. He holds a Ph.D. in Nano Biotechnology, with a focus on recombinant protein production for therapeutic applications, including cell therapy for rheumatoid arthritis. Dr. Hashemzadeh has received numerous accolades, including top ranks in his B.Sc., M.Sc., and Ph.D. studies, and has published extensively in reputable journals on topics such as nanotechnology, viral protein production, and cancer treatment. His research expertise spans molecular genetics, genetic engineering, and the development of novel diagnostic methods for biological threats. Dr. Hashemzadeh’s contributions to the field are recognized internationally, making him a prominent figure in biotechnology research, particularly in Iran. His work bridges the gap between cutting-edge biotechnology and practical medical applications, reflecting his dedication to advancing health sciences.

Profile

Education

Dr. Mohammad Sadegh Hashemzadeh boasts an exemplary educational background in biotechnology and medical sciences. He began his academic journey with a Bachelor of Science (B.Sc.) degree, graduating with top honors and consistently ranking first among his peers. Driven by his passion for advanced research, Dr. Hashemzadeh pursued a Master of Science (M.Sc.) degree, where he continued to excel academically and was recognized for his outstanding performance. He then attained his Ph.D. in Nano Biotechnology from Baqiyatallah University of Medical Sciences, a prestigious institution in Iran, where he focused on recombinant protein expression and the application of nanotechnology in medical diagnostics. Following his doctoral studies, Dr. Hashemzadeh undertook postdoctoral research at the Pasteur Institute of Iran, specializing in innovative cell therapy techniques for rheumatoid arthritis. Throughout his education, he has received numerous accolades, including the first prize at the 15th International Congress of Microbiology, underscoring his dedication and excellence in the field. His comprehensive education has provided him with a solid foundation in molecular genetics, genetic engineering, and cutting-edge biotechnological methodologies.

Professional Experience

Dr. Mohammad Sadegh Hashemzadeh is an accomplished Assistant Professor at Baqiyatallah University of Medical Sciences, Tehran, Iran, with a strong background in Medical and Nano Biotechnology. His expertise spans molecular genetics, genetic engineering, and cell culture, focusing on producing recombinant proteins for therapeutic applications. Dr. Hashemzadeh’s research interests include cell therapy for rheumatoid arthritis, recombinant protein production, and viral vector engineering. He has completed a Post-Doc in cell therapy of inflammatory diseases and has been involved in various research projects, including the construction of recombinant viruses and the development of viral-like particles (VLPs) for potential therapeutic use. In addition to his research contributions, Dr. Hashemzadeh is an experienced educator, having taught courses in genetics, immunology, and nanotechnology at both undergraduate and postgraduate levels. His professional achievements are further underscored by his numerous publications in high-impact journals and his recognition through several awards and honors.

Research Interest

Dr. Mohammad Sadegh Hashemzadeh’s research interests primarily focus on the intersection of medical biotechnology and nano-biotechnology. His work spans the development of advanced therapeutic applications, particularly in molecular genetics, genetic engineering, and cell therapy for inflammatory diseases like rheumatoid arthritis. He is deeply engaged in the production of recombinant proteins, utilizing cell culture techniques to develop viral vectors and virus-like particles (VLPs) for potential cancer treatments and vaccine development. His research also includes exploring the role of peptide nucleic acids (PNAs) in detecting and treating diseases caused by biological threat agents. Additionally, Dr. Hashemzadeh investigates the application of oncolytic viruses in cancer therapy and the development of novel diagnostic methods using nanotechnology. His work is aimed at translating cutting-edge biotechnological advancements into practical solutions for complex medical challenges, contributing to the fields of virology, immunology, and therapeutic protein production.

Research Skills

Dr. Mohammad Sadegh Hashemzadeh possesses a diverse and advanced skill set in the field of biotechnology and nanotechnology. His expertise encompasses molecular genetics, genetic engineering, and cell culture, with a focus on producing recombinant proteins for therapeutic applications. His research is distinguished by his proficiency in the development and application of viral vectors and protein-based vaccines, particularly in the context of cell therapy and vaccine production. Dr. Hashemzadeh has extensive experience in the expression, solubilization, and purification of recombinant proteins, utilizing techniques such as real-time PCR and nanotechnology for diagnostic and therapeutic purposes. His work involves the synthesis and characterization of nanomaterials and viral-like particles (VLPs), contributing to advancements in diagnostic methods and biological threat detection. His skills are supported by a robust publication record in international journals, reflecting his significant contributions to the fields of molecular biotechnology and medical research.

Award and Recognition

Dr. Mohammad Sadegh Hashemzadeh has garnered notable recognition for his exceptional contributions to the fields of biotechnology and nanotechnology. His academic journey is marked by distinguished achievements, including being first-ranked among his peers during his MSc and PhD studies, and receiving accolades such as the First Prize at the 15th International Congress of Microbiology in 2014. His innovative research has been published in prestigious journals, underscoring his influence in the scientific community. Dr. Hashemzadeh’s work on the development of recombinant proteins and viral protein vaccines, as well as his significant contributions to the understanding of biological threat agents through nanotechnology, has earned him commendation. His dedication to advancing medical biotechnology and his role in pioneering research in cell therapy and genetic engineering reflect his outstanding contributions and make him a deserving candidate for further recognition and awards.

Conclusion

Dr. Mohammad Sadegh Hashemzadeh is a highly qualified candidate for the Research for Best Researcher Award, with a solid academic foundation, a track record of excellence in research, and contributions to medical biotechnology and nanotechnology. His continuous pursuit of innovative research and dedication to teaching underscore his suitability for this award. However, to further strengthen his candidacy, increased focus on collaborative research, securing research funding, and enhancing the practical application of his work could be beneficial.

Publications Top Notes

Zinc Oxide Nanoparticles and Cancer Chemotherapy: Helpful Tools for Enhancing Chemo-sensitivity and Reducing Side Effects?
- Authors: Vaghari-Tabari, M., Jafari-Gharabaghlou, D., Mohammadi, M., Hashemzadeh, M.S.
- Journal: Biological Trace Element Research
- Year: 2024
- Volume and Issue: 202(5), pp. 1878–1900
- Citations: 3
Therapeutic Effects of IL-1RA, M2 Cells, and Their Synergistic Impact on a Mouse Model of Rheumatoid Arthritis
- Authors: Hashemzadeh, M.S., Ghaleh, H.E.G., Mohammadi, M., Rezaei, E., Alishiri, G.
- Journal: Advanced Pharmaceutical Bulletin
- Year: 2024
- Volume and Issue: 14(2), pp. 483–495
- Citations: 0
Correction: Biosynthesis of a VLP-type nanocarrier specific to cancer cells using the BEVS expression system for targeted drug delivery (Journal of Genetic Engineering and Biotechnology, (2023), 21, 1, (20), 10.1186/s43141-023-00479-9)
- Authors: Hashemzadeh, M.S., Gharari, N.
- Journal: Journal of Genetic Engineering and Biotechnology
- Year: 2023
- Volume and Issue: 21(1), 40
- Citations: 1
Biosynthesis of a VLP-type nanocarrier specific to cancer cells using the BEVS expression system for targeted drug delivery
- Authors: Hashemzadeh, M.S., Gharari, N.
- Journal: Journal of Genetic Engineering and Biotechnology
- Year: 2023
- Volume and Issue: 21(1), 20
- Citations: 3
Utilization of Freeze-Thawing Method for High-level Expression of Functional Human Epidermal Growth Factor (hEGF)
- Authors: Mohammadi, M., Ghanbari, S., Emamgholi, A., Hashemzadeh, M.S.
- Journal: International Journal of Peptide Research and Therapeutics
- Year: 2023
- Volume and Issue: 29(3), 38
- Citations: 1
Utilization of SUMO Tag and Freeze-thawing Method for a High-level Expression and Solubilization of Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) Protein in E. coli
- Authors: Mohammadi, M., Taheri, R.A., Bemani, P., Farnoosh, G., Amini, R.
- Journal: Protein and Peptide Letters
- Year: 2022
- Volume and Issue: 29(7), pp. 605–610
- Citations: 4
Evaluation of the acute and 28-day sub-acute intravenous toxicity of α-l-guluronic acid (ALG; G2013) in mice
- Authors: Mahdian-Shakib, A., Hashemzadeh, M.S., Anissian, A., Oraei, M., Mirshafiey, A.
- Journal: Drug and Chemical Toxicology
- Year: 2022
- Volume and Issue: 45(1), pp. 151–160
- Citations: 6
The role of bacterial superantigens in the immune response: From biology to cancer treatment
- Authors: Hashemzadeh, M.S., Tapeh, B.E.G., Mirhosseini, S.A.
- Journal: Current Cancer Therapy Reviews
- Year: 2021
- Volume and Issue: 17(1), pp. 21–34
- Citations: 1
Expression, solubilization, refolding and final purification of recombinant proteins as expressed in the form of “classical inclusion bodies” in e. coli
- Authors: Hashemzadeh, M.S., Mohammadi, M., Ghaleh, H.E.G., Choopani, A., Panda, A.K.
- Journal: Protein and Peptide Letters
- Year: 2021
- Volume and Issue: 28(2), pp. 2–10
- Citations: 16
Detection of West Nile virus by real-time PCR in crows in northern provinces of Iran
- Authors: Sharti, M., Amouakbari, M.J., Pourjabari, K., Omidifar, A., Dorostkar, R.
- Journal: Journal of Vector Borne Diseases
- Year: 2020
- Volume and Issue: 57(1), pp. 37–39
- Citations: 2